InnoCan Pharma Corporation
INNPF
$0.132
-$0.0031-2.30%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -290.00K | 337.00K | -1.77M | -883.00K | -2.03M |
| Total Depreciation and Amortization | 9.00K | 10.00K | 10.00K | 8.00K | 9.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 436.00K | 13.00K | 1.42M | -143.00K | 1.41M |
| Change in Net Operating Assets | -1.16M | 315.00K | -408.00K | -293.00K | -113.00K |
| Cash from Operations | -1.00M | 675.00K | -747.00K | -1.31M | -718.00K |
| Capital Expenditure | -6.00K | -3.00K | -2.00K | -9.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | -32.00K |
| Cash from Investing | -6.00K | -3.00K | -2.00K | -9.00K | -32.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6.00K | -5.00K | -5.00K | -5.00K | -5.00K |
| Issuance of Common Stock | 395.00K | 0.00 | 619.00K | 584.00K | 762.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 470.00K | 0.00 | 836.00K | 539.00K | 691.00K |
| Cash from Financing | 859.00K | -5.00K | 1.45M | 1.12M | 1.45M |
| Foreign Exchange rate Adjustments | 18.00K | -73.00K | 9.00K | 63.00K | -47.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -132.00K | 594.00K | 710.00K | -139.00K | 651.00K |
